Raymond James & Associates’s Cameco CCJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$340K Hold
9,700
﹤0.01% 3336
2024
Q2
$485K Buy
+9,700
New +$492K ﹤0.01% 3096
2022
Q3
Sell
-16,000
Closed -$42K 3973
2022
Q2
$42K Buy
+16,000
New +$404K ﹤0.01% 3808
2021
Q4
Sell
-33,500
Closed -$114K 4153
2021
Q3
$114K Buy
+33,500
New +$634K ﹤0.01% 3808
2019
Q3
Sell
-12,000
Closed -$14K 3621
2019
Q2
$14K Hold
12,000
﹤0.01% 3571
2019
Q1
$29K Buy
+12,000
New +$144K ﹤0.01% 3509

Other funds holding CCJ

Raymond James & Associates's CCJ Position: Q3 2024 in Review

Raymond James & Associates reduced its Cameco (CCJ) stake by 2.3% in Q3 2024, selling an estimated $386K and leaving 383,420 shares worth $18.3M. The position accounts for 0.01% of the portfolio, ranked #862.

Raymond James & Associates first reported a position in CCJ in Q2 2014 and has held it in 35 quarters since. The position peaked at $19.3M in Q2 2024. 679 funds tracked by Wall St. Rank hold CCJ as of Q3 2024.

  • Raymond James & Associates held 383,420 shares of Cameco worth $18.3M as of Q3 2024.
  • Raymond James & Associates sold 8,846 Cameco shares in Q3 2024, an estimated $386K.
  • Cameco made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #862 holding.
  • Raymond James & Associates first reported a position in Cameco in Q2 2014 and has held it in 35 quarters since.
  • Raymond James & Associates's Cameco position peaked at $19.3M in Q2 2024.
  • 679 funds tracked by Wall St. Rank held Cameco as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.